4//SEC Filing
Hamel Lawrence G 4
Accession 0000899243-18-023787
CIK 0001427925other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 6:06 AM ET
Size
5.7 KB
Accession
0000899243-18-023787
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Common Stock
2018-08-31$1.49/sh+6,876$10,245→ 24,371 total
Holdings
- 41,964(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the Company's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Non-reportable acquisition of 1,116 shares of common stock through the Company's Employee Stock Purchase Plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 6:06 AM ET
- Size
- 5.7 KB